Sunday, March 3, 2013 Saturday, March 2, 2013 Friday, March 1, 2013- Who's the Frailest Big Pharma of All?at Motley Fool (Fri, Mar 1)
- Bad Pharma And The Statin Warsat Forbes (Fri, Mar 1)
- Mylan Just Got More Interestingat Motley Fool (Fri, Mar 1)
- State pumps Western Mass. schools with $9M to support life sciencesat bizjournals.com (Fri, Mar 1)
- Should VIVUS Just Forget This Drug?at Motley Fool (Fri, Mar 1)
- Bayer Reports Higher RevenuesZacks (Fri, Mar 1)
- Auxilium Beats on All FrontsZacks (Fri, Mar 1)
- Do We Really Need Head-To-Head Comparison Trials With Statins To Improve Cardiac Health?at Forbes (Fri, Mar 1)
- The Zacks Analyst Blog Highlights: Bayer, Novartis, Pfizer, Eli Lilly and UnileverZacks (Fri, Mar 1)
Thursday, February 28, 2013- Do These Pipeline Drugs Hold the Key to AbbVie's Future?at Motley Fool (Thu, Feb 28)
- 101 Reasons to Stay Away From Drugs for This Diseaseat Motley Fool (Thu, Feb 28)
- PFIZER INC Files SEC form 10-K, Annual ReportEDGAR Online (Thu, Feb 28)
- Mylan’s CEO Says Strides Deal Helps Biotechnology Pushat Bloomberg (Thu, Feb 28)
- Priority Review for Bayer's DrugZacks (Thu, Feb 28)
- Mylan rises on purchase of injectable drug makerAP (Thu, Feb 28)
- Why Is the Blockbuster Model Breaking?at Motley Fool (Thu, Feb 28)
- The Zacks Analyst Blog Highlights: Bayer, Novartis, Pfizer, Eli Lilly and MicrosoftZacks (Thu, Feb 28)
- You Have to Love a Lucrative 'Drug Deal'at TheStreet (Thu, Feb 28)
- You Have to Love a Lucrative 'Drug Deal'TheStreet (Thu, Feb 28)
- UPDATE 2-Bayer shares at record after upbeat drug sales viewat Reuters (Thu, Feb 28)
Wednesday, February 27, 2013Add PFE News to My Yahoo!   | |
|
0.19(0.65%) May 23, 4:00PM EDT|After Hours
:
29.14